- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/79 - Benzo [b] furansHydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 307/79
Total number of patents in this class: 513
10-year publication summary
41
|
25
|
38
|
40
|
23
|
29
|
26
|
35
|
29
|
14
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2708 |
15 |
Autifony Therapeutics Limited | 48 |
13 |
Bristol-myers Squibb Company | 4880 |
9 |
Sanofi | 4072 |
9 |
Janssen Pharmaceutica N.V. | 3394 |
8 |
Vanda Pharmaceuticals, Inc. | 361 |
8 |
Novartis AG | 10744 |
7 |
Idemitsu Kosan Co., Ltd. | 4224 |
7 |
CHDI Foundation, Inc. | 106 |
7 |
LG Chem, Ltd. | 17635 |
6 |
Daewoong Pharmaceutical Co., Ltd. | 320 |
6 |
Queen's University at Kingston | 536 |
6 |
The Scripps Research Institute | 1346 |
6 |
SFC Co., Ltd. | 321 |
6 |
H. Lundbeck A/S | 1250 |
6 |
Genentech, Inc. | 3976 |
5 |
Merck Patent GmbH | 5815 |
5 |
Medshine Discovery Inc. | 598 |
5 |
Nippon Shinyaku Co., Ltd. | 322 |
5 |
Piramal Enterprises Limited | 156 |
5 |
Other owners | 369 |